Activity Costs Sample Clauses

Activity Costs. The actual [*] costs to be incurred by Lonza to implement the [*] Project as currently projected by the Parties are [*] (the “Activity Costs”). Such Activity Costs shall be borne by Genentech. Lonza shall invoice Genentech for a) [*] of the expected Activity Costs prior to commencing the [*] Project and b) the balance of actual Activity Costs incurred upon completing the [*] Project and concurrent with such invoice, Lonza shall provide Genentech with a written report summarizing the activities completed and the Activity Costs incurred by Lonza in support of such activities. Genentech shall pay all undisputed invoices within [*] of receipt thereof. In the event that Genentech believes that an invoice is incorrect, it will inform Lonza within [*] of receipt and such disputed amount will be investigated by the parties. Once the dispute has been resolved, Genentech shall pay the corrected invoice within [*] of receipt thereof.
AutoNDA by SimpleDocs
Activity Costs. TenX shall pay to Genmab any Activity Costs and related FTE Costs incurred by Genmab after the Effective Date up until Closing, within seven (7) calendar days, with a five (5) day cure period, upon receipt of invoices from Genmab on a weekly basis, subject to weekly discussions and agreement between the Parties as to such costs. The Activity Costs and related FTE Costs shall not exceed [**] US Dollars ($[**]) per month, excluding the TenX authorized activities by vendors relating to the stability testing and other CMC activities. In addition, TenX shall pay to Genmab, to the extent TenX requests Genmab to undertake, any Activity Costs and related FTE Costs to implement any activities for which TenX is financially responsible pursuant to the Transfer Plan (as defined below) as such costs shall be discussed and agreed to by the Parties. In case of termination of the Agreement TenX shall pay to Genmab any Activity Costs and related FTE Costs that TenX has approved or authorized Genmab to perform, including such costs incurred after termination. In case an Activity Cost reimbursable to Genmab under this Agreement will exceed [**] US Dollars ($[**]), TenX shall pay such amount in advance upon the request of Genmab.
Activity Costs. The PCT in agreeing to this Community Pharmacy Local Enhanced Service (CPLES), in no way commit themselves to the capital expenditure or revenue consequences of any equipment necessary for particular procedures covered by this enhanced service. Providers will be reimbursed at the following rate/s: ITEM PAYMENT Consultation Fee £15.00 per consultation Emergency Hormonal Contraception – Levonelle® 1500 £5.20 +VAT @ 20% = £6.24 per item Pregnancy Testing (£27.00 for 20) £1.35 per test Payment should be claimed by the Provider(s) on a monthly basis on the relevant claim form/spreadsheet provided by the PCT. All completed forms must be returned no later than the 5th of the following month. The PCT will reimburse on a monthly basis and be identifiable as Local Scheme 5.
Activity Costs. The PCT in agreeing to this enhanced service in no way commit themselves to the capital expenditure or revenue consequences of the equipment necessary for particular procedures covered by this enhanced service. For the purpose of this enhanced service, an episode of care has been defined as a completed 4–week assessment. However, it is expected that if patients require support after this point, that care will be provided. Providers will be reimbursed at the following rate/s: ITEM PAYMENT Initial Consultation fee - which includes completing an MDS form and performing a screening spirometry test and recording result. Maximum of 2 initial consultations per patient per year. £10.00 per initial consultation A payment by results (PBR) per smoke free patient as measured by a carbon monoxide monitor at week 4 assessment with a fully completed MDS. £35.00 for a 4 week quitter. An additional payment for those successful quitters who are eligible for free prescriptions as declared on MDS £5.00 Please ensure you have completed all the requested information including occupation data and postcode. Payment for any Initial Consultation fee should be claimed on submission of a Smoking Cessation claim form, in conjunction with a completed the corresponding fully completed and signed MDS form(s) by the providers on a monthly basis. The PBR payment should be claimed for on submission of the same Smoking Cessation claim form, in conjunction with a completed PBR evidence form and the corresponding fully completed and signed MDS form(s) (within ten days of 4 week assessment). By ensuring you have fully completed the PBR evidence form correctly, it will automatically confirm on the Smoking Cessation claim form if you qualify to receive the additional payment of £5.00 per successful quitter(s) who are eligible for free prescriptions as declared on the MDS form. Payment may be withheld/delayed should an MDS/Evidence/Claim forms not arrive within the allotted timescale, are not fully completed or have incorrect information. Incomplete MDS/Evidence/Claim forms will be returned to the Provider. Should this occur the fully completed MDS/Evidence/Claim forms must be returned to the PCT within 15 working days. Providers will only be paid under PBR for patients who successfully complete the 4 week course and quit smoking. All fully completed MDS/Evidence/Claim forms must be returned no later than the 5th of the following month to: Xxxx Xxxxx, Stop Smoking Secretary, Pontefract Health Cent...

Related to Activity Costs

  • Direct Costs Insert the major cost elements. For each element, consider the application of the paragraph entitled “Costs Requiring Prior Approval” on page 1 of these instructions.

  • Project Costs Simultaneously with the execution of this Agreement, the Company shall disclose to the Department all of the Project Costs which the Company seeks to include for purposes of determining the limitation of the amount of the Credit pursuant to Section 5-30 of the Act and provide to the Department a Schedule of Project Costs in the form as attached hereto as Exhibit C.

  • Development Costs With respect to activities prior to the Amendment Effective Date, each Party was to pay [*] of the total Direct Development Costs of a Product incurred in accordance with the Development Budget (as defined in the Original Agreement). Notwithstanding anything in this Article 6 of this Agreement or in any other provision of this Agreement to the contrary, with respect to activities on and after the Amendment Effective Date, subject to Sections 3.1.2, Alimera will be solely responsible for, and shall pay one hundred percent (100%) of, all development costs of a Product, including Direct Development Costs. Notwithstanding anything in this Article 6 of this Agreement or in any other provision of this Agreement to the contrary, (i) all payments owing by CDS hereunder with respect to development activities prior to the Amendment Effective Date are hereby deemed fully paid by CDS (or waived, to the extent such waiver may be required), including any Development Payments, Compounded Development Payments, Determined Disputed Costs and Compounded Disputed Costs (as all defined in the Original Agreement), further including any penalties and interest which might have accrued with respect thereto, and further including all CDS payments deferred pursuant to that February 11, 2008 letter agreement sent by CDS and executed by CDS and Alimera regarding deferral of payments under the Original Agreement as of such date; (ii) all payments owing by Alimera hereunder with respect to development activities prior to the Amendment Effective Date are hereby deemed fully paid by Alimera (or waived, to the extent such waiver may be required), including any Development Payments, Compounded Development Payments, Determined Disputed Costs and Compounded Disputed Costs (as all defined in the Original Agreement), and further including any penalties and interest which might have accrued with respect thereto; and (iii) subject to Sections 3.1.1 and 3.1.2, from and after the Amendment Effective Date, CDS will have no liability whatsoever hereunder for any past, present or future development costs, including Direct Development Costs (which includes those incurred before, on and after the Amendment Effective Date), and instead Alimera shall have sole liability therefor.

  • Reimbursable Costs 5.3.1. To be considered eligible for reimbursement, costs have to be: • actually incurred, individually identifiable and verifiable, as backed by copies of supporting evidence, as the case may be in the Contractor’s official bookkeeping; this means that no lump sums will be eligible for reimbursement; • necessary in order to perform the tasks as specified in the Terms of Reference (Annex 2); and • cost effective and providing value for money

  • Indirect Costs If indirect costs are charged, the Subrecipient will develop an indirect cost allocation plan for determining the appropriate Grantee share of administrative costs and shall submit such plan to the Grantee for approval.

  • Administrative Costs Administrative costs will not be included in the budget neutrality agreement, but the state must separately track and report additional administrative costs that are directly attributable to the demonstration. All administrative costs must be identified on the Forms CMS-64.10 Waiver and/or 64.10P Waiver.

  • Program Costs 3.1 The Province will pay the University of British Columbia’s Faculty of Medicine for the costs of the Participant’s Postgraduate Medical Education. Annually, the cost to the Province to fund the Participant’s Postgraduate Medical Education is approximately $150,000, including the Participant’s salary and benefits.

  • Personnel Costs The actual Worker Wage Rate for Contractor’s hourly employees and the Monthly Salary Rate of Contractor’s salaried personnel who are identified to Owner in advance and in writing but only for the time actually stationed at the Project site with Owner’s prior consent. The Project Manager’s Monthly Salary Rate may be included in the General Conditions Costs only when the Project Manager is directly located on and managing the Project. All personnel costs are subject to audit to determine the actual cost of the wages, salaries and allowable employer contributions incurred by the Contractor for services performed for the Project.

  • Disbursements to Contractors to Pay Costs of the Project The Recipient shall require that as work on the Project and as specified in its contract is performed a Contractor shall promptly submit a detailed project specific invoice to the Project Manager. Within three (3) Business Days following receipt of such invoice from a Contractor, the Project Manager shall review the invoice and, if found to be accurate, shall so certify in writing, forwarding such certification together with a copy of the invoice to the Chief Fiscal Officer. Within five (5) Business Days following receipt of such invoice and certification from the Project Manager, the Chief Fiscal Officer shall conduct such reviews as he considers appropriate and, if he approves such invoice, shall submit to the Director a Disbursement Request together with the information and certifications required by this Section 6(b). The dollar amount set forth in the Disbursement Request shall be calculated based on the Participation Percentage as set forth originally in Appendix D of this Agreement or as may be adjusted from time to time to account for changed conditions in the project financing scheme. Within five (5) Business Days following receipt of the Disbursement Request and all required information and certifications, the Director shall, if such items are deemed by the Director to be accurate and completed, initiate a voucher in accordance with applicable State requirements for the payment of the amount set forth in the Disbursement Request. Upon receipt of a warrant from the Auditor of State drawn in connection with a voucher initiated in accordance with the terms of the preceding sentence, the Director shall forward it by regular first class United States mail or electronic funds transfer, to the contractor or other authorized recipient designated in the Disbursement Request. Prior to any disbursement from the Fund, the following documents shall be submitted to the Director by the Recipient:

  • Incidental Costs The MCP shall bear the sole expense of all costs to mitigate any harmful effect, of any breaches or security incidents which were caused by the MCP, or its subcontractors, in violation of the terms of this Agreement. These costs will include, but are not limited to, the cost of investigation, remediation and assistance to the affected individuals, entities or other authorities.

Time is Money Join Law Insider Premium to draft better contracts faster.